Posted by Michael Wonder on 20 Oct 2025
PHARMAC proposes greater transparency for medicine funding decisions
20 October 2025 - PHARMAC is proposing changes to bring greater transparency and clarity to how medicine funding applications are managed on the Options for Investment list.
The approach would allow PHARMAC to decline applications that have remained in the lowest-ranked group for more than two years - helping people better understand which medicines are unlikely to be funded and why.
